[1]
|
Benson, V. and Marano, M.A. (1998) Current Estimates from the National Health Interview Survey, 1995. National Center for Health Statistics. Vital Health Stat 10 (199). http://www.cdc.gov/nchs/data/series/sr_10/10_199_1.pdf
|
[2]
|
Adler, A.J., Eames, K.T., Funk, S. and Edmunds, W.J. (2014) Incidence and Risk Factors for Influenza-Like-Illness in the UK: Online Surveillance Using Flusurvey. BMC Infectious Diseases, 14, 232.
http://dx.doi.org/10.1186/1471-2334-14-232
|
[3]
|
Molinari, N.A., Ortega-Sanchez, I.R., Messonnier, M.L., Thompson, W.W., Wortley, P.M., Weintraub, E. and Bridges, C.B. (2007) The Annual Impact of Seasonal Influenza in the US: Measuring Disease Burden and Costs. Vaccine, 25, 5086-5096. http://dx.doi.org/10.1016/j.vaccine.2007.03.046
|
[4]
|
Wu, S., Metcalf, J.P. and Wu, W. (2011) Innate Immune Response to Influenza Virus. Current Opinion in Infectious Diseases, 24, 235-240. http://dx.doi.org/10.1097/QCO.0b013e328344c0e3
|
[5]
|
van de Sandt, C.E., Kreijtz, J.H. and Rimmelzwaan, G.F. (2012) Evasion of Influenza A Viruses from Innate and Adaptive Immune Responses. Viruses, 4, 1438-1476. http://dx.doi.org/10.3390/v4091438
|
[6]
|
Iwasaki, A. and Pillai, P.S. (2014) Innate Immunity to Influenza Virus Infection. Nature Reviews. Immunology, 14, 315-328. http://dx.doi.org/10.1038/nri3665
|
[7]
|
Hurt, A.C., Hui, D.S., Hay, A. and Hayden, F.G. (2015) Overview of the 3rd Isirv-Antiviral Group Conference— Advances in Clinical Management. Influenza and Other Respiratory Viruses, 9, 20-31.
http://dx.doi.org/10.1111/irv.12293
|
[8]
|
Klepser, M.E. (2014) Socioeconomic Impact of Seasonal (Epidemic) Influenza and the Role of Over-the-Counter Medicines. Drugs, 74, 1467-1479. http://dx.doi.org/10.1007/s40265-014-0245-1
|
[9]
|
Tripathi, S., White, M.R. and Hartshorn, K.L. (2015) The Amazing Innate Immune Response to Influenza A Virus Infection. Innate Immunity, 21, 73-98. http://dx.doi.org/10.1177/1753425913508992
|
[10]
|
Epstein, O.I. (2008) Ultralow Doses (History of One Research). Publishing Office of the Russian Academy of Medical Sciences, Moscow. http://materiamedicacompany.com/en/Epstein_eng.pdf
|
[11]
|
Le Goffic, R., Pothlichet, J., Vitour, D., Fujita, T., Meurs, E., Chignard, M. and Si-Tahar, M. (2007) Cutting Edge: Influenza A Virus Activates TLR3-Dependent Inflammatory and RIG-I-Dependent Antiviral Responses in Human Lung Epithelial Cells. Journal of Immunology, 178, 3368-3372. http://dx.doi.org/10.4049/jimmunol.178.6.3368
|
[12]
|
Guillot, L., Le Goffic, R., Bloch, S., Escriou, N., Akira, S., Chignard, M. and Si-Tahar, M. (2005) Involvement of Toll-Like Receptor 3 in the Immune Response of Lung Epithelial Cells to Double-Stranded RNA and Influenza A Virus. The Journal of Biological Chemistry, 280, 5571-5580. http://dx.doi.org/10.1074/jbc.M410592200
|
[13]
|
Goffic, R.L., Balloy, V., Lagranderie, M., Alexopoulou, L., Escriou, N., Flavell, R., Chignard, M. and Si-Tahar, M. (2006) Detrimental Contribution of the Toll-Like Receptor (TLR)3 to Influenza A Virus-Induced Acute Pneumonia. PLoS Pathogens, 2, e53. http://dx.doi.org/10.1371/journal.ppat.0020053
|
[14]
|
Burleson, G.R. and Burleson, F.G. (2007) Influenza Virus Host Resistance Model. Methods, 41, 31-37.
http://dx.doi.org/10.1016/j.ymeth.2006.09.007
|
[15]
|
Heads of Medicines Agencies Homeopathic Medicinal Product Working Group (HMPWG) (2007) Points to Consider on Non-Clinical Safety of Homeopathic Medicinal Products of Botanical, Mineral and Chemical Origin.
http://www.hma.eu/uploads/media/PtC_HMP_non_biological_safety_01.pdf
|
[16]
|
Weber, O. (2009) The Role of Viruses in the Etiology and Pathogenesis of Common Cold. In: Eccles, R. and Weber, O., Eds., Common Cold, Birkhauser Advances in Infectious Diseases, Basel, 107-115.
http://dx.doi.org/10.1007/978-3-7643-9912-2_5
|
[17]
|
Hewson, C.A., Jardine, A., Edwards, M.R., Laza-Stanca, V. and Johnston, S.L. (2005) Toll-Like Receptor 3 Is Induced by and Mediates Antiviral Activity against Rhinovirus Infection of Human Bronchial Epithelial Cells. Journal of Virology, 79, 12273-12279. http://dx.doi.org/10.1128/JVI.79.19.12273-12279.2005
|
[18]
|
Barrett, B., Brown, R.L., Mundt, M.P., Thomas, G.R., Barlow, S.K., Highstrom, A.D. and Bahrainian, M. (2009) Validation of a Short Form Wisconsin Upper Respiratory Symptom Survey (WURSS-21). Health and Quality of Life Outcomes, 7, 76. http://dx.doi.org/10.1186/1477-7525-7-76
|
[19]
|
NIH Health Care Systems Research Collaboratory (2014) Patient-Reported Outcomes. In: Rethinking Clinical Trials: A Living Textbook of Pragmatic Clinical Trials. http://sites.duke.edu/rethinkingclinicaltrials/patient-reported-outcomes
|
[20]
|
Perales-Linares, R. and Navas-Martin, S. (2013) Toll-Like Receptor 3 in Viral Pathogenesis: Friend or Foe? Immunology, 140, 153-167. http://dx.doi.org/10.1111/imm.12143
|
[21]
|
Osborne, R.H., Norquist, J.M., Elsworth, G.R., Busija, L., Mehta, V., Herring, T. and Gupta, S.B. (2011) Development and Validation of the Influenza Intensity and Impact Questionnaire (FluiiQ?). Value in Health, 14, 687-699.
http://dx.doi.org/10.1016/j.jval.2010.12.005
|